Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model

Samar Masoumi Moghaddam, Kristen Starbuck, Robert McGray, Ariel Francois, Kunle Odunsi, Emese Zsiros

Research output: Contribution to conference › Poster › peer-review

Original language	English
Pages	956
DOIs	https://doi.org/10.1158/1538-7445.AM2017-956
Publication status	Published - Jul 2017
Event	Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017 - Washington, United States of America Duration: 1 Apr 2017 → 5 Apr 2017

Conference	Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017
Abbreviated title	AACR 2017
Country/Territory	United States of America
City	Washington
Period	1/04/17 → 5/04/17

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Masoumi Moghaddam, S., Starbuck, K., McGray, R., Francois, A., Odunsi, K., & Zsiros, E. (2017). Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model. 956. Poster session presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017, Washington, District of Columbia, United States of America. https://doi.org/10.1158/1538-7445.AM2017-956

@conference{16b7647c7cfc4386a5248d18627dc1e1,

title = "Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model",

author = "\{Masoumi Moghaddam\}, Samar and Kristen Starbuck and Robert McGray and Ariel Francois and Kunle Odunsi and Emese Zsiros",

year = "2017",

month = jul,

doi = "10.1158/1538-7445.AM2017-956",

language = "English",

pages = "956",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017, AACR 2017 ; Conference date: 01-04-2017 Through 05-04-2017",

}

Masoumi Moghaddam, S, Starbuck, K, McGray, R, Francois, A, Odunsi, K & Zsiros, E 2017, 'Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model', Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017, Washington, United States of America, 1/04/17 - 5/04/17 pp. 956. https://doi.org/10.1158/1538-7445.AM2017-956

Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model. / Masoumi Moghaddam, Samar; Starbuck, Kristen ; McGray, Robert et al.
2017. 956 Poster session presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017, Washington, District of Columbia, United States of America.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model

AU - Masoumi Moghaddam, Samar

AU - Starbuck, Kristen

AU - McGray, Robert

AU - Francois, Ariel

AU - Odunsi, Kunle

AU - Zsiros, Emese

PY - 2017/7

Y1 - 2017/7

U2 - 10.1158/1538-7445.AM2017-956

DO - 10.1158/1538-7445.AM2017-956

M3 - Poster

SP - 956

T2 - Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017

Y2 - 1 April 2017 through 5 April 2017

ER -

Masoumi Moghaddam S, Starbuck K, McGray R, Francois A, Odunsi K, Zsiros E. Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model. 2017. Poster session presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR) 2017, Washington, District of Columbia, United States of America. doi: 10.1158/1538-7445.AM2017-956